FDAnews Device Daily Bulletin
Feb. 15, 2005 | Vol. 2 No. 32
VNUS Medical Technologies has announced that the February issue of Dermatologic Surgery published four-year follow-up results on the Closure procedure -- an endovenous radio frequency treatment of venous reflux, which is often an underlying cause of painful varicose veins.
Mentor has announced the U.S. launch of its new Genesis product line for the treatment of erectile dysfunction.
Maxxon has announced the current status of the Maxxon Safety Syringe and the results to date of the SEC civil action against the company.
A new skin patch has been developed to measure glucose levels without the need of finger-prick tests.
ADM Tronics Unlimited has announced that Ivivi Technologies, a subsidiary of ADM Tronics, filed a registration statement on Form SB-2 with the SEC relating to a proposed underwritten initial public offering (IPO) of shares of its common stock, no par value.
Karl Storz, the medical instruments and devices company, has demonstrated the capabilities of their newly developed Integrated Operating Room at Arab Health 2005.
Abbott and OraSure Technologies have announced an agreement for the distribution of OraSure Technologies' OraQuick ADVANCE rapid antibody test for the detection of antibodies to the Human Immunodeficiency Virus Type 1 (HIV-1) and Type
Nymox Pharmaceutical has announced there will be distribution agreements for the marketing and sale of its AlzheimAlert test kit with medical diagnostic companies in Europe.
VIASYS Healthcare and InnoMed Technologies have amicably settled their differences in the patent litigation between them, that they have entered into a settlement agreement, the terms of which are confidential, and that under the agreement, VIASYS is free to sell its LYRA nasal cannula interface device in its present form.
Covalon Technologies has entered into an exclusive distribution agreement with Hartmann-Conco to distribute Covalon collagen wound dressings under the brand ColActive.
West Pharmaceutical Services has announced its acquisition of Monarch Analytical Laboratories of Maumee, Ohio.
Metro government agreed to buy $50,000 worth of life-saving equipment from a California firm whose heart-shocking devices have failed in the past during emergencies, federal documents and interviews show. Cardiac Science manufactures automatic external defibrillators that are used to treat sudden heart attacks.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.